Send feedback

APP p.Ala713Val

c.2138C>T · rs1800557 · VCV98237

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.823 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00636%, nfe)
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Alzheimer disease

Computational evidence

Protein change
AlphaMissense0.823likely pathogenic
REVEL0.928moderately pathogenic-leaning
SaProtLLR -5.81tolerated
⇒ AlphaMissense and REVEL call this damaging; SaProt does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.9, phastCons 1
Regional constrainto/e 0.84unconstrained · MANE · 289 kb · p 2e-07 · regional, not allelic
Overall
CADD29.7PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00636% European (non-Finnish) · 75/1,179,914 alleles
Filtering AF 0.00519% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00474%
Overall 0.00527% 85/1,613,762 alleles · very rare exomes 79/1,461,776 · genomes 6/151,986 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.008% 12,496
European (non-Finnish)grpmax 0.00636% 15,732
Finnishnot grpmax-eligible 0.00313% 31,988
East Asian 0.00223% 44,882
Admixed American 0.00167% 59,976
African / African-American 0.00134% 74,872

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
APP
Protein
p.Ala713Val
Coding
c.2138C>T
MANE Select
NM_000484
dbSNP
rs1800557
Type
single nucleotide variant
Location
chr21:25891795 (GRCh38)
Gene constraint
LOEUF 0.41 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 68.11 · 263 PDB
Residue 713
a UniProt-annotated variant site (in ad1); a UniProt-annotated variant site (in one chronic schizophrenia patient; uncertain significance); an α-helix; the 'interaction with psen1' region; a functional site (cleavage; by gamma-secretase; site 2)
Full APP gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/app-p-ala713val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown